GOALS

The Medical Advisory Board constitutes a central body within Pharmact Holding AG and its subsidiaries.

As a consultative committee with interdisciplinary medical expertise, it plays a key role in ensuring that strategic decisions are made on a scientifically sound, regulatory-compliant, and market-oriented basis.

A highly qualified panel of medical experts is essential to ensure that innovations meet current medical standards, clinical trial processes are optimised, and new products achieve market authorization more efficiently.

SPONSOR

Pharmact Pharmaceuticals GmbH particularly benefits from this expertise by utilising the scientific counsel of the Board to reinforce its standing within the competitive environment and to continue building research partnerships with esteemed academic establishments.

This scientific knowledge supports the potential to refine market positioning and foster groundbreaking collaborations with leading medical institutions and universities.

EXTRACT – MEMBERS

Prof. Dr. med. Stefanie Kürten
Anatomical Institute of the University of Bonn, Germany

Dr. med Logan James Yilmaz
Cardiologist,Clinical Research & Trials University of Zürich, Schweiz

Prof. Dr. med. Andreas Kurth
Director Center for Orthopaedic and Trauma Surgery, Frankfurt, Germany
Clinical Research Bone Tumor, Osteology
Vorsitzender Dachverband Osteologie e. V.

Prof. Dr. med. Robert Pflugmacher
Head Physician Clinic for Orthopedics, Mechernich, Germany

Prof. Dr. med. Abderahman Machraoui
Cardiologist, Clinical Trials; Bochum, Germany / Maroc

Dr. med. Florian Beyer
Rheumatology  Osteology (DGO)  Orthopedics, Kaiserslautern, Germany

PD Dr. med. Bronek M. Boszcyk
Visiting Professor Nottingham Trent University